| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 19.168 | 15.894 | 8.381 | 6.954 | - | - | - | - | - |
| Total Income - EUR | 0 | 19.168 | 15.894 | 8.381 | 6.954 | - | - | - | - | - |
| Total Expenses - EUR | 69 | 8.012 | 14.110 | 12.268 | 15.356 | - | - | - | - | - |
| Gross Profit/Loss - EUR | -69 | 11.156 | 1.784 | -3.887 | -8.401 | - | - | - | - | - |
| Net Profit/Loss - EUR | -69 | 10.773 | 1.623 | -3.971 | -8.471 | - | - | - | - | - |
| Employees | 0 | 1 | 1 | 2 | 2 | - | - | - | - | - |
Check the financial reports for the company - Mm Transforexim Exclusiv Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 111 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Current Assets | 56 | 11.569 | 16.465 | 16.139 | 11.797 | - | - | - | - | - |
| Inventories | 11 | 0 | 7.216 | 9.910 | 9.887 | - | - | - | - | - |
| Receivables | 0 | 0 | 8.688 | 6.219 | 1.902 | - | - | - | - | - |
| Cash | 45 | 11.569 | 561 | 9 | 9 | - | - | - | - | - |
| Shareholders Funds | -24 | 10.750 | 12.191 | 7.996 | -629 | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | - | - | - | - |
| Debts | 191 | 820 | 4.274 | 8.142 | 12.427 | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Mm Transforexim Exclusiv Srl